Recombinant

Camidanlumab Tesirine (IL2RA) – Research Grade Biosimilar

CATALOG NUMBER: 10-866

Clonality:
Recombinant Monoclonal
Conjugate:
Unconjugated
Specifications
Source Species:
CHO cells
Source Species:
CHO cells
Immunogen:
Homo sapiens / IL2RA [Homo sapiens]
Conjugate:
Unconjugated
Purification:
>95%
Clonality:
Recombinant Monoclonal
Isotype:
IgG1-kappa
Buffer:
PBS buffer pH7.5
Concentration:
batch dependent
Storage Conditions:
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 °C for 1-2 weeks. Store at -20 °C for 12 months. Store at -80 °C for long term storage.
Additional Names:
ADCT-301,HuMax-TAC-ADC
User Note:
Optimal dilutions for each application to be determined by the researcher.
Background:
Camidanlumab tesirine (ADCT-301) is an antibody-drug conjugate (ADC) combining Genmab’s HuMax®-TAC antibody and ADC Therapeutics’ PBD-based warhead and linker technology. Camidanlumab tesirine targets CD25, which is expressed on a variety of hematological tumors and shows limited expression on normal tissues, except for regulatory T cells (Tregs), which are known to be immunosuppressive. Camidanlumab tesirine is in development under an agreement between Genmab and ADC Therapeutics, under which Genmab owns 25% of the product rights.

FOR RESEARCH USE ONLY

For additional information, visit ProSci’s Terms & Conditions Page.

Disclaimer:
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.

CATALOG NUMBER:

10-866

List Size:
0.1 mg

List Price:

$470.00

Out of stock

Shipping Info
Customize your order
Custom Antibody Services

New & Featured Products

CATALOG NUMBER: PM-7369-HRP

CATALOG NUMBER: PM-7369-biotin

CATALOG NUMBER: PM-7369